Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group
Frontiers in Public Health · 06.07.2026 · 14
DOI: 10.3389/fpubh.2026.1811039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 06.07.2026. Verfasst von C E Osakwe und 24 weiteren Autor:innen. Beteiligte Einrichtung: Forum for Collaborative Research, University of California, Berkeley, DC, United States. Hauptthemen laut MEDLINE: HIV Infections, Lactation, Pre-Exposure Prophylaxis, Pregnancy Complications, Infectious. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, University of California Berkeley.
Abstract (Originalsprache)
Despite a 60% decline in new HIV infections since 1995, significant challenges persist. In 2023, 1.3 million new HIV infections occurred, with 645,500 in sub-Saharan Africa, where cisgender adolescent girls and women represent over two-thirds of new cases. Approximately one-quarter of vertical HIV transmissions are linked to infections during pregnancy and lactation, yet data on PrEP use in these populations remains generally limited due to their exclusion from clinical trials, despite a recent movement toward inclusion, such as in the PURPOSE 1 trials evaluating the efficacy and safety of lenacapavir. This data gap is concerning given that women face an elevated risk of HIV acquisition during pregnancy. Despite this heightened risk, access to PrEP remains restricted among these groups. This article, based on insights from a multi-regional and multi-sectoral working group convened by the Forum for Collaborative Research between January 2024 and February 2025, addresses this critical issue. The working group, comprising stakeholders from regulatory agencies, research, industry, and communities, held meetings and a scientific symposium to inform evidence-based strategies for improving the inclusion of pregnant and lactating women in PrEP trials. The working group identified key barriers, including ethical concerns, limited safety data, minimal community engagement, regulatory gaps, weak incentives, and limited surveillance capacity. They recommend reframing pregnant and lactating women as needing protection through research, alongside standardized data systems, stronger incentives, global collaboration, and digital innovation to ensure equitable inclusion in HIV prevention efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Forum for Collaborative Research, University of California, Berkeley, DC, United States.
- National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria.
- Independent Global Health Consultant, Longmeadow, MA, United States.
- South African Health Products Regulatory Authority, Pretoria, South Africa.
- Department of Medicine, Division of Infectious Diseases, the University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
- Gilead Sciences, Inc., Foster, CA, United States.
Förderung
- World Health Organization
- University of California Berkeley
Zitieren
APA
Osakwe, C. E., Schaefer, R., Donaldson, L., Abiodun, A. S., Chatani-Gada, M., Chigome, A. K., Day, S., Deaton, C., Elemuwa, U. G., Ingold, H., Joseph Davey, D., Kersey, K., Lamprianou, S., Lyerly, A. D., Noguchi, L. M., Nyambayo, P. P. M., Mpaso, C., Robertson, M. N., Renaud, F., …, & Long-Acting PrEP during Pregnancy and Lactation Working Group (2026). Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1811039
Vancouver
Osakwe CE, Schaefer R, Donaldson L, Abiodun AS, Chatani-Gada M, Chigome AK, et al. Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1811039
BibTeX
@article{Osakwe2026,
author = {Osakwe, C E and Schaefer, R and Donaldson, L and Abiodun, A S and Chatani-Gada, M and Chigome, A K and Day, S and Deaton, C and Elemuwa, U G and Ingold, H and Joseph Davey, D and Kersey, K and Lamprianou, S and Lyerly, A D and Noguchi, L M and Nyambayo, P P M and Mpaso, C and Robertson, M N and Renaud, F and Sehloho, T and van Wyk, J and Vannappagari, V and Warren, M and Miller, V and Long-Acting PrEP during Pregnancy and Lactation Working Group, Long-Acting PrEP during Pregnancy and Lactation Working Group},
title = {Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1811039}
}
EUVIMED